3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
7
Colorectal Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Pheochromocytoma
1
Pediatric Solid Tumor
1
Paraganglioma
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphangioleiomyomatosis
1
Lipodystrophy, Familial Partial
1
Kidney Neoplasms
1
Histiocytosis, Non-Langerhans-Cell
1
Interventions
pirtobrutinib
6
Cyclophosphamide
6
Mycophenolic Acid
5
fludarabine phosphate
4
fludarabine
4
Rituximab
4
Melphalan
4
Azacitidine
4
venetoclax
3
ibrutinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Mesna
3
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Lenalidomide
2
Cyclosporine
2
Busulfan
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
zanubrutinib
1
ruxolitinib
1
ponatinib
1
pembrolizumab
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
cedazuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Genetic Testing
×
1 year
×
Clear all
No trials found.